Urogenital immune signatures are associated with birth outcomes after maternal urinary tract infection
Science Translational Medicine · 2026
DOI: 10.1126/scitranslmed.aea1228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Samantha Ottinger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Urinary Tract Infections, Pregnancy Outcome, Pregnancy Complications, Infectious. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Preterm birth is the leading cause of infant mortality, resulting in more than 1 million neonatal deaths globally each year. Maternal urinary tract infection (UTI) during pregnancy increases risk for preterm birth; however, biological processes mediating UTI-associated preterm birth are not well described. We established a murine maternal UTI model in which challenge with uropathogenic Escherichia coli (UPEC) initiated preterm labor and birth in about half of dams. Although bacterial burdens were similar, dams experiencing preterm birth displayed excessive bladder inflammation, elevated placental and decidual cytokines, higher proportions of male fetuses, and lower maternal serum interleukin-10 (IL-10) compared with nonlaboring dams. Exogenous IL-10 or lymph node sequestration of T cells reduced placental type 17 T helper cells (T H 17 cells) and abrogated preterm birth. In a human pregnancy cohort, we correlated urinary cytokines with birth outcomes and urine culture status. These analyses yielded an exploratory, noninvasive culture-agnostic system for evaluating preterm birth risk, implicating T cell–related cytokines including IL-10, IL-15, GM-CSF, and RANTES. These findings demonstrate that our murine model provides a platform to investigate immunological and microbial factors governing UTI-associated preterm birth and, coupled with patient samples, may be used to identify candidate biomarkers and mechanistic targets for future investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
- Department of Pathology, University of South Alabama, Mobile, AL, USA.
- Department of Microbiology and Immunology, University of South Alabama, Mobile, AL, USA.
- Department of Integrative Physiology, Baylor College of Medicine, Houston, TX, USA.
- Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, TX, USA.
ORCID-Profile: Samantha Ottinger, Vicki Mercado-Evans, Holly Branthoover, Jacob J Zulk, Marlyd E Mejia, Zainab A Hameed, Ryan Walde, Rachel C Fleck, Christopher S Ward, Allyson E Shea, Kathryn A Patras
Förderung
- NICHD NIH HHS
- NIH HHS
- NIAID NIH HHS
- NCRR NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NHGRI NIH HHS
Zitieren
APA
Ottinger, S., Larson, A. B., Mercado-Evans, V., Branthoover, H., Zulk, J. J., Serchejian, C., Ogilvie, L., Mejia, M. E., Hameed, Z. A., Walde, R., Fleck, R. C., Ward, C. S., Shea, A. E., & Patras, K. A. (2026). Urogenital immune signatures are associated with birth outcomes after maternal urinary tract infection. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aea1228
Vancouver
Ottinger S, Larson AB, Mercado-Evans V, Branthoover H, Zulk JJ, Serchejian C, et al. Urogenital immune signatures are associated with birth outcomes after maternal urinary tract infection. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aea1228
BibTeX
@article{Ottinger2026,
author = {Ottinger, Samantha and Larson, Addison B and Mercado-Evans, Vicki and Branthoover, Holly and Zulk, Jacob J and Serchejian, Camille and Ogilvie, Libbie and Mejia, Marlyd E and Hameed, Zainab A and Walde, Ryan and Fleck, Rachel C and Ward, Christopher S and Shea, Allyson E and Patras, Kathryn A},
title = {Urogenital immune signatures are associated with birth outcomes after maternal urinary tract infection},
journal = {Science Translational Medicine},
year = {2026},
doi = {10.1126/scitranslmed.aea1228}
}
EUVIMED